MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea · Delayed Price · Currency is KRW 1,900.00
+100.00 (5.56%)
At close: Sep 10, 2026
MEDIZEN HUMANCARE Market Cap
MEDIZEN HUMANCARE has a market cap or net worth of 4.03 billion as of September 11, 2026. Its market cap has increased by 2.94% in one year.
Market Cap
4.03B
Enterprise Value
n/a
Revenue
583.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,900.00
ChartMarket Cap Chart
Since April 5, 2017, MEDIZEN HUMANCARE's market cap has decreased from 20.81B to 4.03B, a decrease of -80.62%. That is a compound annual growth rate of -15.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.03B | 2.94% |
| Dec 30, 2025 | 3.92B | -46.03% |
| Dec 30, 2024 | 7.26B | -21.25% |
| Dec 28, 2023 | 9.22B | -33.88% |
| Dec 29, 2022 | 13.94B | -13.57% |
| Dec 30, 2021 | 16.13B | -15.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 453.99B |
| DreamCIS | 81.18B |
| P&K Skin Research Center | 52.56B |
| HLB bioStep | 39.49B |
| Kolmar BioTech | 36.86B |
| SLS BIO | 26.89B |
| C&R Research | 23.56B |
| DT&CRO CO. | 20.06B |